Increased opioid receptor binding and G protein coupling in the accumbens and ventral tegmental area of postnatal day 2 rats.
In some regions of the developing rat brain such as the nucleus accumbens (Acb), mu opioid (MOP) receptor specific binding in the perinatal period exceeds that in the adult. To investigate the significance of these developmental changes, MOP and nociceptin/orphanin FQ (NOP) receptor binding and G protein coupling as determined by GTPgammaS binding experiments were examined in mesolimbic regions of postnatal day 2 (P2) pups and compared to those of their dams. Acb of the P2 pup exhibited 2-fold greater MOP receptor specific binding than that of the dam. In the ventral tegmental area (VTA), NOP specific binding was about 2-fold higher in the P2 pup. A correlation was found between MOP and NOP binding and their coupling to G protein on dam and P2 pup brain sections. However, the magnitude of increases in MOP and NOP receptor G protein coupling to G protein in P2 pups exceeded the 2-fold differences in binding between pups and dams. Furthermore, the amplitude of the MOP receptor G protein coupling in female P2 Acb was greater than increases in male P2 pup Acb. Differences in MOP and NOP binding and G protein coupling in other mesolimbic regions between P2 pups and dams were rarely observed. The data indicate that greater binding and G protein coupling of MOP and NOP receptors occur in discrete, mesolimbic regions of P2 pups when compared to their dams. It may be of significance that these brain regions, Acb and VTA, are undergoing maturation on P2.
Hou
Yanning
Y
Department of Biochemistry & Molecular Biology, St. Louis University School of Medicine, MO 63104, USA.
Belcheva
Mariana M
MM
Clark
Amy L
AL
Zahm
Daniel S
DS
Coscia
Carmine J
CJ
D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D001345:Autoradiography; D044482:Benzeneacetamides; D020881:Enkephalin, D-Penicillamine (2,5)-; D005260:Female; D016244:Guanosine 5'-O-(3-Thiotriphosphate) / Q000378:metabolism; D009714:Nucleus Accumbens / Q000378:metabolism*; D018847:Opioid Peptides; D011247:Pregnancy; D011759:Pyrrolidines; D051381:Rats; D017207:Rats, Sprague-Dawley; D043562:Receptors, G-Protein-Coupled / Q000378:metabolism*; D011957:Receptors, Opioid / Q000378:metabolism*; D017450:Receptors, Opioid, mu / Q000378:metabolism; D017557:Ventral Tegmental Area / Q000378:metabolism*; D000094942:Nociceptin Receptor; D000097629:Nociceptin
D044482:Benzeneacetamides; D020881:Enkephalin, D-Penicillamine (2,5)-; D016244:Guanosine 5'-O-(3-Thiotriphosphate); D018847:Opioid Peptides; D011759:Pyrrolidines; D043562:Receptors, G-Protein-Coupled; D011957:Receptors, Opioid; D017450:Receptors, Opioid, mu; D000094942:Nociceptin Receptor; D000097629:Nociceptin; C045444:U 69593; C000722285:Oprl1 protein, rat